![John R. Uhrin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John R. Uhrin
Nessuna posizione attualmente
Profilo
Before joining Harbert in 2002, Mr. Uhrin was employed by BioCryst Pharmaceuticals Inc., where he served as Vice President of Corporate Development.
While there, he managed in- and out-licensing of products and technologies to execute research, discovery functions, and commercialization strategies; he coordinated contractual arrangements with corporate partners, and developed and maintained relationships with the biotech industry and academic research institutions.
He was also employed with Genentech, Inc. as Director of Special Markets/Managed Care, where he directed a multi-state domestic and international region, focusing on managed care organizations, insurance companies, HMO's, and Integrated Networks.
Before joining Genentech, Mr. Uhrin spent ten years at Eli Lilly & Company.
Mr. Uhrin received a Bachelor of Science in Pharmacy from the University of North Carolina at Chapel Hill.
Precedenti posizioni note di John R. Uhrin
Società | Posizione | Fine |
---|---|---|
HMC-Virginia, Inc.
![]() HMC-Virginia, Inc. Investment ManagersFinance HMC Virginia Inc (HMC Virginia) is a venture capital subsidiary of Harbert Management Corp founded in 1993 by Wayne L. Hunter & William W. Brooke. The firm is headquartered in Richmond, Virginia. | Investitore di Private Equity | 01/02/2010 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Direttore/Membro del Consiglio | - |
BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di John R. Uhrin
The University of North Carolina at Charlotte | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
Aziende private | 2 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
HMC-Virginia, Inc.
![]() HMC-Virginia, Inc. Investment ManagersFinance HMC Virginia Inc (HMC Virginia) is a venture capital subsidiary of Harbert Management Corp founded in 1993 by Wayne L. Hunter & William W. Brooke. The firm is headquartered in Richmond, Virginia. | Finance |
- Borsa valori
- Insiders
- John R. Uhrin